Science Explorer Back to mapMap

Most cited papers from Multidisciplinary Association for Psychedelic Studies

Multidisciplinary Association for Psychedelic Studies

What are the most cited papers from Multidisciplinary Association for Psychedelic Studies?

The most cited paper from Multidisciplinary Association for Psychedelic Studies is "MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study" (Jennifer Mitchell et al., 2021), with 1,000 citations. Next come "Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases" (764) and "The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study" (681).

Showing 50 of 58 papers. Every paper with more than 50 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study Jennifer Mitchell et al. · Nature Medicine Open access 10 May 2021 1,000
2 Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases Peter Gasser, Dominique H. Holstein, Yvonne Anne Michel et al. · The Journal of Nervous and Mental Disease Open access 4 Mar 2014 764
3 The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study Michael C. Mithoefer, Mark T. Wagner, Ann T. Mithoefer et al. · Journal of Psychopharmacology Open access 19 Jul 2010 681
4 Single-Dose Psilocybin Treatment for Major Depressive Disorder Charles L. Raison et al. · JAMA Open access 31 Aug 2023 543
5 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial Michael C. Mithoefer, Ann T. Mithoefer, Allison A. Feduccia et al. · The Lancet Psychiatry May 2018 447
6 MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial Jennifer Mitchell et al. · Nature Medicine Open access 14 Sep 2023 438
7 Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study Michael C. Mithoefer, Mark T. Wagner, Ann T. Mithoefer et al. · Journal of Psychopharmacology Open access 20 Nov 2012 379
8 Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer Gabrielle Agin-Liebes, Tara C. Malone, Matthew M. Yalch et al. · Journal of Psychopharmacology 9 Jan 2020 363
9 Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study Alicia L. Danforth, Charles S. Grob, Christopher M. Struble et al. · Psychopharmacology Open access 8 Sep 2018 289
10 3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial Marcela Ot’alora G., Jim Grigsby, Bruce Poulter et al. · Journal of Psychopharmacology Open access 29 Oct 2018 234
11 MDMA-Assisted Psychotherapy Using Low Doses in a Small Sample of Women with Chronic Posttraumatic Stress Disorder José Carlos Bouso, Rick Doblin, Magı́ Farré et al. · Journal of Psychoactive Drugs Sep 2008 209
12 Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline Allison A. Feduccia, Lisa Jerome, Berra Yazar‐Klosinski et al. · Frontiers in Psychiatry Open access 12 Sep 2019 173
13 MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study Philip E. Wolfson, Julane Andries, Allison A. Feduccia et al. · Scientific Reports Open access 24 Nov 2020 172
14 Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy Mark T. Wagner, Michael C. Mithoefer, Ann T. Mithoefer et al. · Journal of Psychopharmacology Open access 21 Jun 2017 165
15 Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study Geoff Noller, Chris Miles Frampton, Berra Yazar‐Klosinski · The American Journal of Drug and Alcohol Abuse Open access 12 Apr 2017 152
16 Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer STEPHEN D. ROSS, Gabrielle Agin-Liebes, Sharon L. Lo et al. · ACS Pharmacology & Translational Science Open access 18 Mar 2021 139
17 How do psychedelics work? Robin Lester Carhart-Harris · Current Opinion in Psychiatry 3 Nov 2018 139
18 The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial Marcel O. Bonn‐Miller, Sue Sisley, Paula Riggs et al. · PLoS ONE Open access 17 Mar 2021 133
19 5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines Lindsay P. Cameron, Seona D. Patel, Maxemiliano V. Vargas et al. · ACS Chemical Neuroscience Open access 11 Jan 2023 122
20 The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy Harry R. Sumnall, Jon C. Cole, Lisa Jerome · Journal of Psychopharmacology 31 Aug 2006 118
21 Playing With Fear: A Field Study in Recreational Horror Marc Malmdorf Andersen, Uffe Schjoedt, Henry C. W. Price et al. · Psychological Science Open access 2 Nov 2020 115
22 The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) Johannes T. Reckweg, Malin Vedøy Uthaug, Attila Szabó et al. · Journal of Neurochemistry Open access 12 Feb 2022 113
23 MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults Alicia L. Danforth, Christopher M. Struble, Berra Yazar‐Klosinski et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry Open access 9 Apr 2015 110
24 Canalization and plasticity in psychopathology Robin Lester Carhart-Harris, Shamil Chandaria, David Erritzøe et al. · Neuropharmacology Open access 27 Dec 2022 109
25 A Clinical Plan for MDMA (Ecstasy) in the Treatment of Posttraumatic Stress Disorder (PTSD): Partnering with the FDA Rick Doblin · Journal of Psychoactive Drugs Jun 2002 99
26 Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey Sandeep Manel Nayak, Hillary Jackson, Nathan D. Sepeda et al. · Frontiers in Psychiatry Open access 19 Sep 2023 92
27 Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments Kyle T. Greenway, Nicolas Garel, Lisa Jerome et al. · Expert Review of Clinical Pharmacology Jun 2020 92
28 Laboratory models of post-traumatic stress disorder: The elusive bridge to translation Joseph E. Dunsmoor, Josh M. Cisler, Gregory A. Fonzo et al. · Neuron Open access 23 Mar 2022 91
29 MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trial Candice M. Monson, Anne Catherine Wagner, Ann T. Mithoefer et al. · European Journal of Psychotraumatology Open access 7 Dec 2020 91
30 The Past and Future of Psychedelic Science: An Introduction to This Issue Richard Doblin, Merete Bruun Christiansen, Lisa Jerome et al. · Journal of Psychoactive Drugs Open access 15 Mar 2019 89
31 The association of psychedelic use and opioid use disorders among illicit users in the United States Vincent D. Pisano, Nathaniel P Putnam, Hannah M. Kramer et al. · Journal of Psychopharmacology 14 Feb 2017 87
32 MDMA-assisted therapy significantly reduces eating disorder symptoms in a randomized placebo-controlled trial of adults with severe PTSD Timothy D. Brewerton, Julie B. Wang, Adèle Lafrance et al. · Journal of Psychiatric Research Open access 5 Mar 2022 85
33 Potential Psychiatric Uses for MDMA BB Yazar‐Klosinski, MC Mithoefer · Clinical Pharmacology & Therapeutics Open access 10 Nov 2016 81
34 Diversity, equity, and access in psychedelic medicine Monnica T. Williams, Beatriz Caiuby Labate · Journal of Psychedelic Studies Open access 27 Dec 2019 80
35 A Single Belief-Changing Psychedelic Experience Is Associated With Increased Attribution of Consciousness to Living and Non-living Entities Sandeep Manel Nayak, Roland R. Griffiths · Frontiers in Psychology Open access 28 Mar 2022 78
36 Progress and promise for the MDMA drug development program Allison A. Feduccia, Julie A. Holland, Michael C. Mithoefer · Psychopharmacology 20 Nov 2017 78
37 Is ecstasy perceived to be safe? A critical survey Alex Gamma, Lisa Jerome, Matthias E. Liechti et al. · Drug and Alcohol Dependence 5 Oct 2004 78
38 The Psychedelic Future of Post-Traumatic Stress Disorder Treatment Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic et al. · Current Neuropharmacology Open access 5 Jan 2024 77
39 Therapeutic mechanisms of psychedelics and entactogens Boris Dov Heifets, David E. Olson · Neuropsychopharmacology Open access 24 Jul 2023 71
40 Psychedelic-assisted psychotherapy to treat psychiatric and existential distress in life-threatening medical illnesses and palliative care STEPHEN D. ROSS, Manish Agrawal, Roland R. Griffiths et al. · Neuropharmacology Open access 27 Jun 2022 71
41 Expectancy Effects in Psychedelic Trials Balázs Szigeti, Boris Dov Heifets · Biological Psychiatry Cognitive Neuroscience and Neuroimaging 20 Feb 2024 69
42 The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD Christopher R. N. Nicholas, Julie B. Wang, Allison R. Coker et al. · Drug and Alcohol Dependence Open access 11 Feb 2022 68
43 Modeling gene × environment interactions in PTSD using human neurons reveals diagnosis-specific glucocorticoid-induced gene expression Carina Seah et al. · Nature Neuroscience Open access 20 Oct 2022 65
44 Psychedelic Knowledge and Opinions in Psychiatrists at Two Professional Conferences: An Exploratory Survey Brian Scott Barnett, Yvan Beaussant, Franklin King et al. · Journal of Psychoactive Drugs 19 Aug 2021 65
45 3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in rats Holly Sue Hake, Jazmyne K.P. Davis, River R. Wood et al. · Physiology & Behavior Open access 4 Dec 2018 65
46 History and Future of the Multidisciplinary Association for Psychedelic Studies (MAPS) Amy Emerson, Linnae Ponté, Lisa Jerome et al. · Journal of Psychoactive Drugs 2014 65
47 How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change Richard J. Zeifman, Anne Catherine Wagner, Candice M. Monson et al. · Journal of Affective Disorders 3 May 2023 62
48 Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial Jordan Sloshower, Richard J. Zeifman, Jeffrey R. Guss et al. · Scientific Reports Open access 17 Apr 2024 61
49 Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities David B. Yaden, Matthew W. Johnson, Roland R. Griffiths et al. · The International Journal of Neuropsychopharmacology Open access 10 May 2021 61
50 An Integrated theory of false insights and beliefs under psychedelics Hugh T. McGovern, Hilary Jane Grimmer, Manoj K. Doss et al. · Communications Psychology Open access Aug 2024 57

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.